Removal of Amphotericin B

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Mon, 08/22/2016 - 09:28
#1
Hao Nguyen
Hao Nguyen's picture
Offline
Last seen: 1 year 9 months ago
Joined: 10/13/2015 - 16:19
Removal of Amphotericin B

Hello Everyone,

I am writing today to ask about your institution's practice with regards to amphotericin B.

1) Does your institution carry the conventional form and any of the lipid-based formulations? If so, what is the reasoning for carrying both?

2) Did your institution carry both formulations (conventional and lipid-based) in the past and then removed one formulation? If so, what was the reasoning for the removal?

3) If your institution removed amphotericin B (either formulations) from the formulary, was there any push-back/resistance?

Thank you,

Top